Navigation Links
Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc.
Date:11/17/2009

ls, and any other statements about Trimeris' managements' future expectations, beliefs, goals, plans or prospects constitute forward looking statements. Any statements that are not statements of historical fact (including statements containing the words "believes," "plans," "anticipates," "expects," "estimates" and similar expressions) should also be considered to be forward looking statements. These forward looking statements involve known and unknown risks and uncertainties that may cause Trimeris' actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward looking statements. Important factors that may cause or contribute to such differences include uncertainties as to the timing of the tender offer and merger; uncertainties as to how many of Trimeris' stockholders will tender their stock in the offer; the risk that competing offers will be made; the possibility that various closing conditions for the transaction may not be satisfied or waived; the effects of disruption from the transaction making it more difficult to maintain relationships with employees, licensees, other business partners or governmental entities; transaction costs; whether results obtained in clinical studies or in preclinical studies will be indicative of results obtained in future clinical trials; whether Trimeris will be able to obtain regulatory approvals and such other factors as are set forth in the risk factors detailed from time to time in Trimeris' periodic reports and registration statements filed with the Securities and Exchange Commission including, without limitation, the risk factors detailed in Trimeris' Form 10-K filed with the Securities and Exchange Commission on March 13, 2009, which are incorporated herein by reference. The forward looking statements are made only as of the date of publication. Except as otherwise required by law, the Company specifically disclaims any obligation to update any o
'/>"/>
SOURCE Arigene Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
2. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
3. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
4. Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study
5. Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon
6. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
7. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
8. Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics
9. Elbit Imaging Ltd. Announces Sale of Plaza Centers Shares
10. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
11. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015   Emerson Ecologics, LLC ... supplements, prescription products and natural health and ... with Anabolic Laboratories, a leading manufacturer of ... new partnership will allow Anabolic Laboratories to ... practitioner segments and provide customers with added ...
(Date:3/2/2015)... Calif. , March 2, 2015 Nevro ... company that has developed and commercialized an innovative, evidence-based ... announced that Brad Vale , PhD, DVM, former ... been appointed to its Board of Directors, effective March ... 30 years of experience in developing, commercializing and investing ...
(Date:3/2/2015)... 2015  BC Technical, the nation,s leading non-OEM ... Systems, a Nuclear Imaging service company providing systems, ... their ongoing vision to provide the best, and ... Technical continues to expand their reach and expertise. ... valuable resources and knowledge in addition to strengthening ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3Nevro Appoints Dr. Brad Vale to its Board of Directors 2BC Technical Acquires Eclipse Systems 2
... 10 Biopure Corporation,(Nasdaq: BPUR ) today announced ... have been published in the June 2008 issue of,the ... an Alternative,to Blood Transfusion: Efficacy and Safety Evaluation in ... "It is gratifying to have experts cull through the ...
... Endpoints for Advair Diskus(R) ... Compared to ... African American,patients with asthma treated with Advair Diskus, a combination ... propionate, had a lower rate of exacerbations when,compared with patients ...
Cached Medicine Technology:Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma 2Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma 2Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma 3
(Date:3/2/2015)... Today the Brain Injury Association of America (BIAA) officially kicked ... support the more than 5.3 million Americans who are living ... nation in observing Brain Injury Awareness Month by conducting an ... the 2015 to 2017 campaign is: Not Alone. , ... general public about the incidence of brain injury and the ...
(Date:3/2/2015)... Market Publishers Ltd is extremely happy ... Global Industry Analysts Inc and recently added to its ... . Through 2018, the global radiation therapy equipment market ... research report suggests a holistic analysis of the situation ... well as covers the top market trends. The publication ...
(Date:3/2/2015)... 02, 2015 Tyrone Christopher, Co-founder of ... medium for the model agency industry, have launched Softcandy.sexy, ... Mango, Passion Fruit, Pink Grapefruit, Pomegranate, and or Vanilla ... 1pm. , At a cost of alienating a few ... fire by announcing the brands commitment and support of ...
(Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
(Date:3/2/2015)... View, CA (PRWEB) March 02, 2015 ... today that it has officially launched a multivitamin ... Gustafsson, head of product development for BNatrl, said ... through feedback from Olympic and other world-class athletes. ... excited to use this pure whole food multivitamin ...
Breaking Medicine News(10 mins):Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... ... a permanent solution to the Medicare physician payment system this year, says MedicareSupplementPlans.com ... Los ... year designed to improve the way Medicare pays physicians while still keeping Medicare costs ...
... , Senate Finance Committee Urged Not to Include ... WASHINGTON, Aug. 7 America,s local and regional independent ... provision imposing a 20% co-pay on laboratory services under Medicare. ... this provision would shift billions of dollars in costs to senior ...
... Duane Reade Holdings, Inc. announced today that its wholly-owned ... had closed their offering of $300.0 million aggregate principal amount ... The Notes bear interest at an annual rate of ... yield to maturity of 12.375%. The Notes were issued ...
... serious cardiovascular issues: study , FRIDAY, Aug. 7 (HealthDay ... is a reliable predictor of cardiovascular complications in people ... -- kidney damage caused by diabetes. , The study ... 2007. Those with increased levels of IgM in their ...
... , , , ... will learn how to use the latest technology to help keep ... California Partnership to End Domestic Violence (CPEDV) and Verizon. , ... the Verizon Foundation, the philanthropic arm of Verizon, is designed to ...
... the Yerkes National Primate Research Center, Emory University, believe ... explored in the development of an effective AIDS vaccine. ... nonhuman primates, they propose an additional new approach to ... in the August issue of Nature Medicine . ...
Cached Medicine News:Health News:Congress Unlikely to Pass Permanent Medicare Physician Payment Fix in 2009, says MedicareSupplementPlans.com 2Health News:Seniors: Get Your Checkbooks Ready 2Health News:Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015 2Health News:Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015 3Health News:Immunoglobulin Can Predict Some Diabetic Complications 2Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 2Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 3Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 4Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 3
Excellent during IOL insertion while pushing the trailing haptic into position. Gently curved shaft and round handle....
Ideal for nucleus manipulation during phacoemulsification. Also used for manipulating and rotating IOLs within the anterior chamber. Round knurled handle...
Short, narrow paddle angled 45 degree inserts through the side port stab incision and is ideal for effective manipulation of the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique. Round knurled handle. Manufactured in titanium....
Medicine Products: